Showing results (1211-1220 of 1,356) with videos related to
Sort By:
Pageof 136
Materials Science & Engineering. C, Materials for Biological Applications|September 13, 2020
ROS-generation and cellular uptake behavior of amino-silica nanoparticles arisen from their uploading by both iron-oxides and hexamolybdenum clustersSvetlana Fedorenko, Julia Elistratova, Alexey Stepanov, et al.Asian Journal of Neurosurgery|January 7, 2020
Endoscopic Transsphenoidal Approach in Treatment of Germinomas of the Chiasmosellar RegionMaxim Alexandrovich Kutin, Dmitry Vladislavovich Fomichev, Alexey Nikolaevich Shkarubo, et al.Physical Review Letters|March 20, 2026
Nonlinear Terahertz Electroluminescence from Dirac-Landau PolaritonsB Benhamou-Bui, C Consejo, S S Krishtopenko, et al.Plos Neglected Tropical Diseases|August 11, 2020
The global progress of soil-transmitted helminthiases control in 2020 and World Health Organization targets for 2030Antonio Montresor, Denise Mupfasoni, Alexei Mikhailov, et al.Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|September 1, 2006
X-ray structural studies of the fungal laccase from Cerrena maximaAndrey V Lyashenko, Isabel Bento, Viatcheslav N Zaitsev, et al.Insect Science|August 25, 2021
Climate shapes the spatiotemporal variation in color morph diversity and composition across the distribution range of Chrysomela lapponica leaf beetleMikhail V Kozlov, Zowi Oudendijk, Anders Forsman, et al.Chemmedchem|September 29, 2015
6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's DiseaseVyacheslav E Semenov, Irina V Zueva, Marat A Mukhamedyarov, et al.The International Journal of Risk & Safety in Medicine|December 8, 2015
6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's diseaseI V Zueva, V E Semenov, M A Mukhamedyarov, et al.Biochimica Et Biophysica Acta. Proteins and Proteomics|June 23, 2019
Characterization of the 20S proteasome of the lepidopteran, Spodoptera frugiperdaOksana I Kravchuk, Yulia V Lyupina, Pavel A Erokhov, et al.Neuro-Oncology|May 31, 2022
Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trialMacarena I de la Fuente, Howard Colman, Mark Rosenthal, et al.Pageof 136